Matías Maestro, Ignacio
Loading...
Email Address
person.page.identifierURI
Birth Date
Job Title
Last Name
Matías Maestro
First Name
Ignacio
person.page.departamento
Ingeniería Eléctrica, Electrónica y de Comunicación
person.page.instituteName
ISC. Institute of Smart Cities
ORCID
person.page.observainves
person.page.upna
Name
- Publications
- item.page.relationships.isAdvisorOfPublication
- item.page.relationships.isAdvisorTFEOfPublication
- item.page.relationships.isAuthorMDOfPublication
2 results
Search Results
Now showing 1 - 2 of 2
Publication Open Access Femtomolar detection by nanocoated fiber label-free biosensors(American Chemical Society, 2018) Chiavaioli, Francesco; Zubiate Orzanco, Pablo; Del Villar, Ignacio; Ruiz Zamarreño, Carlos; Giannetti, Ambra; Tombelli, Sara; Trono, Cosimo; Arregui San Martín, Francisco Javier; Matías Maestro, Ignacio; Baldini, Francesco; Institute of Smart Cities - ISC; Ingeniería Eléctrica y Electrónica; Ingeniaritza Elektrikoa eta Elektronikoa; Gobierno de Navarra / Nafarroako GobernuaThe advent of optical fibre-based biosensors combined with that of nanotechnologies has provided an oppor-tunity for developing in situ, portable, lightweight, versatile and high-performance optical sensing platforms. We report on the generation of lossy mode resonances by the deposition of nm-thick metal oxide films on optical fibres, which makes it possible to measure precisely and accurately the changes in optical properties of the fibre-surrounding medium with very high sensitivity compared to other technology platforms, such as long period gratings or surface plasmon resonances, the gold standard in label-free and real-time biomolecular interaction analysis. This property, combined with the application of specialty structures such as D-shaped fibres, permits enhancing the light-matter interaction. SEM and TEM imaging together with X-EDS tool have been utilised to characterise the two films used, i.e. indium tin oxide and tin dioxide. More-over, the experimental transmission spectra obtained after the deposition of the nanocoatings have been numerically cor-roborated by means of wave propagation methods. With the use of a conventional wavelength interrogation system and ad-hoc developed microfluidics, the shift of the lossy mode resonance can be reliably recorded in response to very low analyte concentrations. Repeated experiments confirm a big leap in performance thanks to the capability to detect femtomolar concentrations in human serum, improving the detection limit by three orders of magnitude when compared with other fibre-based configurations. The biosensor has been regenerated several times by injecting sodium dodecyl sul-phate, which proves the capability of sensor to be reused.Publication Open Access Fiber-based early diagnosis of venous thromboembolic disease by label-free D-dimer detection(Elsevier, 2019) Zubiate Orzanco, Pablo; Urrutia Azcona, Aitor; Ruiz Zamarreño, Carlos; Egea Urra, Josune; Fernández Irigoyen, Joaquín; Giannetti, Ambra; Baldini, Francesco; Díaz Lucas, Silvia; Matías Maestro, Ignacio; Arregui San Martín, Francisco Javier; Santamaría Martínez, Enrique; Chiavaioli, Francesco; Del Villar, Ignacio; Ingeniaritza Elektrikoa, Elektronikoaren eta Telekomunikazio Ingeniaritzaren; Institute of Smart Cities - ISC; Ingeniería Eléctrica, Electrónica y de Comunicación; Gobierno de Navarra / Nafarroako GobernuaD-dimer is a useful diagnostic biomarker for deep vein thrombosis or pulmonary embolism, collectively referred to as venous thromboembolism (VTE). The ability to detect in real-time the amount of D-dimer with a fast and reliable method is a key step to anticipate the appearance of these diseases. Here, the results of a highly specific and sensitive biosensor for the detection of D-dimer based on lossy mode resonance in fiber optics are presented. The unique features of specialty fibers in light management integrated with microfluidics allow detecting D-dimer in human serum with a detection limit of 100 ng/mL, a value 5-fold below the clinical cutoff value. Comparison of the results achieved with mass-spectrometry-based proteomics, which allows for the identification of beta- and gamma-chains of fibrinogen, demonstrates the ability of our platform to specifically (>90%) recognize D-dimer. Therefore, this technology potentially represents a paradigm shift in the development of a simple, high-specificity and label-free biosensing platform, which can be applied to speed up diagnostic healthcare processes of venous thromboembolism toward an early diagnostic and personalized treatment system.